Evidence map›Paper›PMID 28093273›Full record

ArticleBiochimica et biophysica acta. Gene regulatory mechanisms2017

Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expression.

Daniel L Kiss, Catherine E Waters, Iman M Ouda, Joshua C Saldivar, Jenna R Karras, Zaynab A Amin, Seham Mahrous, Teresa Druck, Ralf A Bundschuh, Daniel R Schoenberg and 1 more

Abstract read
In one paragraph

Article in Biochimica et biophysica acta. Gene regulatory mechanisms, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Upregulation of FHIT gene expression in endometrial carcinoma by RNA activation.International journal of clinical and experimental pathology · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Daniel L Kiss *Center for RNA Biology, 484 West 12th Ave., Columbus, OH 43210 USA.
Catherine E Waters *Department of Cancer Biology and Genetics, The Ohio State University, 460 West 12 Ave., Columbus, OH 43210 USA.
Iman M Ouda *Department of Cancer Biology and Genetics, The Ohio State University, 460 West 12 Ave., Columbus, OH 43210 USA.
Joshua C SaldivarDepartment of Cancer Biology and Genetics, The Ohio State University, 460 West 12 Ave., Columbus, OH 43210 USA.
Jenna R KarrasDepartment of Cancer Biology and Genetics, The Ohio State University, 460 West 12 Ave., Columbus, OH 43210 USA.
Zaynab A AminDepartment of Cancer Biology and Genetics, The Ohio State University, 460 West 12 Ave., Columbus, OH 43210 USA.
Seham MahrousDepartment of Clinical Pathology, Faculty of Medicine, 2nd floor, Surgery Hospital, Zagazig University, Zagazig 44519, Egypt.
Teresa DruckDepartment of Cancer Biology and Genetics, The Ohio State University, 460 West 12 Ave., Columbus, OH 43210 USA.
Ralf A BundschuhCenter for RNA Biology, 484 West 12th Ave., Columbus, OH 43210 USA.
Daniel R SchoenbergCenter for RNA Biology, 484 West 12th Ave., Columbus, OH 43210 USA.
Kay HuebnerDepartment of Cancer Biology and Genetics, The Ohio State University, 460 West 12 Ave., Columbus, OH 43210 USA.
The Ohio State University · USZagazig University · EG

Funding

Relationship of Cytoplasmic Capping to Post-transcriptional Gene RegulationR01GM084177 · NIGMS · OHIO STATE UNIVERSITY · PI SCHOENBERG, DANIEL R. · 2010 to 2018
$2.7M
MicroRNA profiles of TN breast cancer to define subgroups and targets for therapyU01CA154200 · NCI · OHIO STATE UNIVERSITY · PI HUEBNER, KAY · 2010 to 2014
$2.3M
Wwox as a Critical Signal Mediator in Breast CancerR01CA120516 · NCI · OHIO STATE UNIVERSITY · PI HUEBNER, KAY · 2006 to 2013
$1.3M
NCI NIH HHS R01 CA120516NCI NIH HHS U01 CA154200NIGMS NIH HHS R01 GM084177
6 · The paper itself

Abstract

FHIT is a genome caretaker gene that is silenced in >50% of cancers. Loss of Fhit protein expression promotes accumulation of DNA damage, affects apoptosis and epithelial-mesenchymal transition, though molecular mechanisms underlying these alterations have not been fully elucidated. Initiation of genome instability directly follows Fhit loss and the associated reduced Thymidine Kinase 1 (TK1) protein expression. The effects on TK1 of Fhit knockdown and Fhit induction in the current study confirmed the role of Fhit in regulating TK1 expression. Changes in Fhit expression did not impact TK1 protein turnover or transcription from the TK1 promoter, nor steady-state levels of TK1 mRNA or turnover. Polysome profile analysis showed that up-regulated Fhit expression resulted in decreased TK1 RNA in non-translating messenger ribonucleoproteins and increased ribosome density on TK1 mRNA. Fhit does not bind RNA but its expression increased luciferase expression from a transgene bearing the TK1 5'-UTR. Fhit has been reported to act as a scavenger decapping enzyme, and a similar result with a mutant (H96) that binds but does not cleave nucleoside 5',5'-triphosphates suggests the impact on TK1 translation is due to its ability to modulate the intracellular level of cap-like molecules. Consistent with this, cells expressing Fhit mutants with reduced activity toward cap-like dinucleotides exhibit DNA damage resulting from TK1 deficiency, whereas cells expressing wild-type Fhit or the H96N mutant do not. The results have implications for the mechanism by which Fhit regulates TK1 mRNA, and more broadly, for its modulation of multiple functions as tumor suppressor/genome caretaker.

Indexed as

Acid Anhydride HydrolasesAmino Acid SubstitutionBis(5'-adenosyl)triphosphataseCell Line, TumorGene Expression Regulation, EnzymologicHumansMutation, MissenseNeoplasm ProteinsPromoter Regions, GeneticRNA, MessengerThymidine KinaseAcid Anhydride HydrolasesBis(5'-adenosyl)triphosphataseNeoplasm ProteinsRNA, MessengerThymidine Kinasethymidine kinase 15′-UTRFhitThymidine kinase 1Translational control

Identifiers

PMID28093273
PMCPMC5325794
OpenAlexW2571747285

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.